InMed Pharmaceuticals (INM) Capital Expenditures (2019 - 2024)
InMed Pharmaceuticals (INM) posted Capital Expenditures of $2.0 for Q1 2024, down 99.98% on a QoQ basis from $12409.0 in Q4 2023, and down 100.0% year-over-year from $133705.0 in Q2 2023.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Capital Expenditures (2019 - 2024) Analysis & Trends
InMed Pharmaceuticals has reported Capital Expenditures for 6 years, with the latest figure at $2.0 in Q1 2024.
- On a quarterly basis, Capital Expenditures fell 100.0% year-over-year to $2.0 in Q1 2024; TTM through Jun 2024 was $9293.0, a 94.19% decrease from a year earlier, with the FY2024 full-year figure at $9293.0, down 94.19% from the prior year.
- Capital Expenditures was $2.0 for Q1 2024 at InMed Pharmaceuticals, down from $12409.0 in the prior quarter.
- The five-year high for Capital Expenditures was $250000.0 in Q3 2021, with the low at -$214445.0 in Q4 2021.
- Average Capital Expenditures over 5 years is $18055.1, with a median of $6174.0 recorded in 2020.
- The sharpest annual moves came in 2021 and 2023: Capital Expenditures tumbled 139350.0% in 2021, then surged 3663.16% in 2023.
- Over 5 years, Capital Expenditures stood at $154.0 in 2020, then sank by 139350.0% to -$214445.0 in 2021, then surged by 97.43% to -$5507.0 in 2022, then soared by 325.33% to $12409.0 in 2023, then plunged by 99.98% to $2.0 in 2024.
- The last three Capital Expenditures figures came in at $2.0 (Q1 2024), $12409.0 (Q4 2023), and -$3118.0 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Corning | 145.72 Bn | 143.22 Bn | 1.63 Bn | 422.00 Mn |
| 2 | Ati | 28.37 Bn | 27.59 Bn | 309.80 Mn | 68.60 Mn |
| 3 | Qnity Electronics | 26.33 Bn | 25.37 Bn | 666.00 Mn | 90.00 Mn |
| 4 | International Flavors & Fragrances | 21.51 Bn | 20.94 Bn | 853.00 Mn | 136.00 Mn |
| 5 | DuPont de Nemours | 17.42 Bn | 15.68 Bn | 639.00 Mn | 76.00 Mn |
| 6 | Avery Dennison | 12.99 Bn | 12.76 Bn | 729.40 Mn | 39.20 Mn |
| 7 | Solstice Advanced Materials | 10.05 Bn | 9.30 Bn | 370.00 Mn | 138.00 Mn |
| 8 | Element Solutions | 8.74 Bn | 8.55 Bn | 334.00 Mn | 27.90 Mn |
| 9 | Eastman Chemical | 7.84 Bn | 7.15 Bn | 560.00 Mn | 100.00 Mn |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 2.00 |
| Dec 31, 2023 | 12,409.00 |
| Sep 30, 2023 | -3,118.00 |
| Jun 30, 2023 | 31,816.00 |
| Mar 31, 2023 | 133,705.00 |
| Sep 30, 2022 | -5,507.00 |
| Jun 30, 2022 | 22,324.00 |
| Mar 31, 2022 | 3,553.00 |
| Dec 31, 2021 | -214,445.00 |
| Sep 30, 2021 | 250,000.00 |
| Dec 31, 2020 | 154.00 |
| Sep 30, 2020 | 14,007.00 |
| Jun 30, 2020 | -923.00 |
| Mar 31, 2020 | 8,795.00 |
| Dec 31, 2019 | 2,171.00 |
| Sep 30, 2019 | 32,530.00 |